225 related articles for article (PubMed ID: 37496062)
1. Diagnostic value and immune infiltration characterization of YTHDF2 as a critical m6A regulator in osteoarthritic synovitis.
Bian A; Wang C; Zhang H; Yan Y; Zhang L; Cheng W
J Orthop Surg Res; 2023 Jul; 18(1):535. PubMed ID: 37496062
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis.
Liu Z; Liu H; Li D; Ma L; Lu T; Sun H; Zhang Y; Yang H
Front Immunol; 2023; 14():1128459. PubMed ID: 37006311
[TBL] [Abstract][Full Text] [Related]
4. m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis.
Hu S; Shen C; Yao X; Zou Y; Wang T; Sun X; Nie M
BMC Med Genomics; 2022 Dec; 15(1):273. PubMed ID: 36585683
[TBL] [Abstract][Full Text] [Related]
5. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss.
Huo J; Chen Q; Zhang Y; Li N; Fu Z; Ma N; Zheng N; Cui N; Li L
Front Genet; 2022; 13():925652. PubMed ID: 36118846
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy.
Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J
Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern analysis of m6A regulators reveals IGF2BP3 as a key modulator in osteoarthritis synovial macrophages.
Lu Y; Zhang H; Pan H; Zhang Z; Zeng H; Xie H; Yin J; Tang W; Lin R; Zeng C; Cai D
J Transl Med; 2023 May; 21(1):339. PubMed ID: 37217897
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
Zhou S; Hua R; Quan S
J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of m6A reader YTHDF2 prognosis, immune infiltration, and related regulatory networks in hepatocellular carcinoma.
Wang H; Cai H; Li L
Heliyon; 2024 Jan; 10(1):e23204. PubMed ID: 38163150
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis.
Wang X; Zhao X; Wang J; Wu H; Cheng Y; Guo Q; Liang T; Zhang G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675186
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
14. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
Front Genet; 2022; 13():1044264. PubMed ID: 36544487
[No Abstract] [Full Text] [Related]
16. A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms.
Chen X; Mo S; Zong L; Yu S; Lu Z; Chen J
Neuroendocrinology; 2022; 112(12):1187-1199. PubMed ID: 35609514
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis identifies potential m6A hub genes in the pathogenesis of intracerebral hemorrhage.
Zhou B
J Neuroimmunol; 2023 Dec; 385():578224. PubMed ID: 37907028
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of m6A-related diagnostic model for psoriasis.
Liu J; Wang Y; Sheng Y; Cai L; Wang Y
PeerJ; 2024; 12():e17027. PubMed ID: 38436011
[TBL] [Abstract][Full Text] [Related]
20. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
